XIAMEN AMOYTOP BIOTECH CO., LTD. Announcement on Obtaining Notice of Approval for Drug Clinical Trial of ACT100 for Injection

About this update from Xiamen Amoytop Biotech Co., Ltd. Class A

XIAMEN AMOYTOP BIOTECH CO., LTD. Announcement on Obtaining Notice of Approval for Drug Clinical Trial of ACT100 for Injection The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Xiamen Amoytop Biotech Co., Ltd. Class A